[go: up one dir, main page]

WO2000008134A3 - SERINE PROTEASE DE HtrA HUMAINE - Google Patents

SERINE PROTEASE DE HtrA HUMAINE Download PDF

Info

Publication number
WO2000008134A3
WO2000008134A3 PCT/EP1999/005528 EP9905528W WO0008134A3 WO 2000008134 A3 WO2000008134 A3 WO 2000008134A3 EP 9905528 W EP9905528 W EP 9905528W WO 0008134 A3 WO0008134 A3 WO 0008134A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
invention concerns
human
serine protease
methods
Prior art date
Application number
PCT/EP1999/005528
Other languages
English (en)
Other versions
WO2000008134A2 (fr
Inventor
Robert Mitchell Crowl
Shou-Ih Hu
Rajendra Durgaprasad Ghai
Jane Vivienne Peppard
Original Assignee
Novartis Ag
Novartis Erfind Verwalt Gmbh
Robert Mitchell Crowl
Hu Shou Ih
Rajendra Durgaprasad Ghai
Jane Vivienne Peppard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Erfind Verwalt Gmbh, Robert Mitchell Crowl, Hu Shou Ih, Rajendra Durgaprasad Ghai, Jane Vivienne Peppard filed Critical Novartis Ag
Priority to AU52904/99A priority Critical patent/AU5290499A/en
Publication of WO2000008134A2 publication Critical patent/WO2000008134A2/fr
Publication of WO2000008134A3 publication Critical patent/WO2000008134A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouvelles matières et de nouveaux procédés servant à détecter l'arthrose et un cancer chez l'homme. Spécifiquement, l'invention concerne un gène et un produit de gène de HtrA humains qui sont exprimés de manière différente lorsqu'on compare un tissu atteint d'arthrose et un tissu non atteint d'arthrose. Un aspect supplémentaire de l'invention concerne des composés qui s'opposent à l'activité biologique de la protéine HtrA et des procédés d'identification de ces composés. Un autre aspect de l'invention concerne des compositions pharmaceutiques contenant ces composés.
PCT/EP1999/005528 1998-08-03 1999-07-31 SERINE PROTEASE DE HtrA HUMAINE WO2000008134A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU52904/99A AU5290499A (en) 1998-08-03 1999-07-31 Human htra serine protease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/128,619 1998-08-03
US12861998A 1998-10-26 1998-10-26

Publications (2)

Publication Number Publication Date
WO2000008134A2 WO2000008134A2 (fr) 2000-02-17
WO2000008134A3 true WO2000008134A3 (fr) 2000-05-11

Family

ID=22436199

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/005528 WO2000008134A2 (fr) 1998-08-03 1999-07-31 SERINE PROTEASE DE HtrA HUMAINE

Country Status (2)

Country Link
AU (1) AU5290499A (fr)
WO (1) WO2000008134A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2081596A4 (fr) * 2006-10-06 2010-07-21 Univ Utah Res Found Procede de detection de maladies et d'affections pathologiques de l' il et traitement de celles-ci
EP2217720A4 (fr) 2007-11-01 2010-12-08 Univ Iowa Res Found Analyse de lieu de rca pour estimer la sensibilité à l'amd et au mpgnii
CN103917556B (zh) 2011-10-14 2018-02-06 霍夫曼-拉罗奇有限公司 抗HtrA1抗体及使用方法
CN108290957B (zh) 2015-10-30 2022-06-17 豪夫迈·罗氏有限公司 抗-HtrA1抗体及其使用方法
WO2017222914A1 (fr) 2016-06-21 2017-12-28 Inception 4, Inc. Dérivés de prolinamide carbocycliques
CA3025253A1 (fr) 2016-06-21 2017-12-28 Orion Ophthalmology LLC Derives heterocycliques de prolinamide
MA45620A (fr) 2016-07-01 2019-05-08 Hoffmann La Roche Oligonucléotides antisens pour la modulation de l'expression de htra1
US20190055564A1 (en) * 2017-06-01 2019-02-21 F. Hoffmann-La Roche Ag Antisense oligonucleotides for modulating htra1 expression
CN111512160B (zh) * 2017-12-21 2024-04-09 豪夫迈·罗氏有限公司 Htra1 rna拮抗剂的伴随诊断

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107980A (ja) * 1995-08-17 1997-04-28 Japan Tobacco Inc 新規生理活性タンパク
EP0828003A2 (fr) * 1996-09-06 1998-03-11 Smithkline Beecham Plc Sérine protéase humaine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107980A (ja) * 1995-08-17 1997-04-28 Japan Tobacco Inc 新規生理活性タンパク
EP0828003A2 (fr) * 1996-09-06 1998-03-11 Smithkline Beecham Plc Sérine protéase humaine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HU ET AL.: "Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage", J. BIOL. CHEM., vol. 273, no. 51, 18 December 1998 (1998-12-18), pages 34406 - 34412, XP002127797 *
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 08 29 August 1997 (1997-08-29) *
ZUMBRUNN ET AL.: "Primary structure of a putative serine protease specific for IGF-binding proteins", FEBS LETTERS, vol. 398, 1996, pages 187 - 192, XP002127796 *

Also Published As

Publication number Publication date
WO2000008134A2 (fr) 2000-02-17
AU5290499A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
Glickman et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction
WO1997033996A3 (fr) Bikunine humaine
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
WO1999015503A3 (fr) Procede de preparation de diaryl pyridines utiles comme inhibiteurs de cox-2
WO2001083774A3 (fr) Nouvelle forme mutante d'arginine deiminase
WO2000008134A3 (fr) SERINE PROTEASE DE HtrA HUMAINE
WO2001010894A3 (fr) Composes et compositions anti-picornavirus; utilisations pharmaceutiques et materiaux employes pour leur synthese
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
ATE297750T1 (de) Verwendung von hsp70 protein
AU2924699A (en) Tryptase inhibitors
AU7408301A (en) Novel target genes for diseases of the heart
WO1999046374A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
WO2003029422A3 (fr) Gene du syndrome de noonan
WO2003076610A3 (fr) Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
WO2002030266A3 (fr) Detection d'adn endommage
WO2000046369A3 (fr) Polynucleotides associes a une maladie du pancreas
WO2001096873A3 (fr) Procede d'identification de proteines a apoptose modifiee
WO2004112575A3 (fr) Amplification et surexpression geniques dans le cancer
AU3556800A (en) Expression of dna or proteins in (c. elegans)
WO2001066709A3 (fr) Enzymes et utilisations les concernant
WO2002064731A3 (fr) Sequences impliquees dans les phenomenes de suppression tumorale reversion tumorale apoptose et/ou resistance aux virus et leur utilisation comme medicaments
PT951471E (pt) Inibidores cicloalquilo de farnesiltransferase de proteinas
WO2002070744A3 (fr) Test de criblage de banque adénovirale destiné à des procédés et à des gènes régulateurs e2f, et compositions destinées au criblage de composés
WO2002000872A3 (fr) Compositions et methodes pour le traitement ou la detection de pathologies neurodegeneratives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 09777498

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA